Govt Job for Ph.D, M.Pharm as Scientist at Govt of India Enterprise

HLL Lifecare Limited (HLL) is a Govt. of India Healthcare products manufacturing and services Company based in Thiruvananthapuram, Kerala, India under the Union Ministry of Health and Family Welfare.

HLL is a global leader in the area of contraceptives, hospital products and healthcare services. With 7 manufacturing units, 7 subsidiary companies, 22 regional offices and having presence in more than 115 countries, HLL is positioned as a total healthcare solution provider catering to the well-being of the society at large.

Post : SCIENTIST E3

Job Description
1. Development of drug delivery systems/ implants for regulated markets
2. Preparation of dossier for regulatory submissions for obtaining marketing clearance in regulated markets
3. Scale up and Technology Transfer
4. Meeting audit as per regulatory requirements

Candidate Profile
Maximum Age: 40 years as on 01.07.2021
Consolidated pay range (For Fixed Term Contract engagement): 35,000 –65,000/- (Senior Manager (E3) per month.

(The consolidated pay will be fixed within the pay range depending on the qualification, experience and the current pay drawn by the candidate. The consolidated pay will be inclusive of all allowances and benefits).

Educational Qualification:
Essential: PhD in Pharmaceutics/ M.Pharm Pharmaceutics

Experience
Essential: Minimum 5 years post qualification for PhD/ Minimum 8 Years post qualification experience for M.Pharm
Desirable: Patents, Technology transfers in novel drug delivery systems

General Conditions
• SC/ST/OBC/PwD candidates will be eligible for relaxation as per Government of India directives.
• Canvassing in any form will be a disqualification.

Location : Anywhere in India

Last Date : 28th July, 2021

Reference Code HLL/HR/015/2021

Related Posts

Maha cops bust three factories, seize drugs worth Rs 56 crore in Bengaluru

The Konkan division of Maharashtra ANTF raided three different locations in Bengaluru, during which the drug manufacturing units were busted. BENGALURU:  While the state government is aiming to make Karnataka…

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

New Delhi: A pharma group has sought extension for those production units that have already submitted upgradation plans and can demonstrate execution progress, even as the drug regulatory authority seems…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Maha cops bust three factories, seize drugs worth Rs 56 crore in Bengaluru

Maha cops bust three factories, seize drugs worth Rs 56 crore in Bengaluru

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US